Evidence map›Paper›PMID 25037309›Full record

ArticleCirculation. Heart failure2014

Urinary composition during decongestive treatment in heart failure with reduced ejection fraction.

Frederik H Verbrugge, Petra Nijst, Matthias Dupont, Joris Penders, W H Wilson Tang, Wilfried Mullens

Abstract read
PubMed Publisher
In one paragraph

Article in Circulation. Heart failure, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 92 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Spot urinary sodium in acute decompensation of advanced heart failure and dilutional hyponatremia: insights from DRAIN trial.Clinical research in cardiology : official journal of the German Cardiac Society · 2020
    Trial
  4. Article
  5. Article
  6. The role of urine sodium in acutely decompensated heart failure.International journal of cardiology. Heart & vasculature · 2024
    Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Usefulness of natriuresis to predict in-hospital diuretic resistance.American journal of cardiovascular disease · 2020
    Article
  17. Review
  18. Review
  19. Article
  20. Diuretic Resistance in Heart Failure.Current heart failure reports · 2019
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Frederik H VerbruggeFrom the Department of Cardiology, Ziekenhuis Oost-Limburg, Genk, Belgium (F.H.V., P.N., M.D., W.M.); Doctoral School for Medicine and Life Sciences (F.H.V., P.N.) and Biomedical Research Institute, Faculty of Medicine and Life Sciences (J.P., W.M.), Hasselt University, Diepenbeek, Belgium; Department of Laboratory Medicine, Ziekenhuis Oost-Limburg, Genk, Belgium (J.P.); and Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, OH (W.H.W.T.).
Petra NijstFrom the Department of Cardiology, Ziekenhuis Oost-Limburg, Genk, Belgium (F.H.V., P.N., M.D., W.M.); Doctoral School for Medicine and Life Sciences (F.H.V., P.N.) and Biomedical Research Institute, Faculty of Medicine and Life Sciences (J.P., W.M.), Hasselt University, Diepenbeek, Belgium; Department of Laboratory Medicine, Ziekenhuis Oost-Limburg, Genk, Belgium (J.P.); and Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, OH (W.H.W.T.).
Matthias DupontFrom the Department of Cardiology, Ziekenhuis Oost-Limburg, Genk, Belgium (F.H.V., P.N., M.D., W.M.); Doctoral School for Medicine and Life Sciences (F.H.V., P.N.) and Biomedical Research Institute, Faculty of Medicine and Life Sciences (J.P., W.M.), Hasselt University, Diepenbeek, Belgium; Department of Laboratory Medicine, Ziekenhuis Oost-Limburg, Genk, Belgium (J.P.); and Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, OH (W.H.W.T.).
Joris PendersFrom the Department of Cardiology, Ziekenhuis Oost-Limburg, Genk, Belgium (F.H.V., P.N., M.D., W.M.); Doctoral School for Medicine and Life Sciences (F.H.V., P.N.) and Biomedical Research Institute, Faculty of Medicine and Life Sciences (J.P., W.M.), Hasselt University, Diepenbeek, Belgium; Department of Laboratory Medicine, Ziekenhuis Oost-Limburg, Genk, Belgium (J.P.); and Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, OH (W.H.W.T.).
W H Wilson TangFrom the Department of Cardiology, Ziekenhuis Oost-Limburg, Genk, Belgium (F.H.V., P.N., M.D., W.M.); Doctoral School for Medicine and Life Sciences (F.H.V., P.N.) and Biomedical Research Institute, Faculty of Medicine and Life Sciences (J.P., W.M.), Hasselt University, Diepenbeek, Belgium; Department of Laboratory Medicine, Ziekenhuis Oost-Limburg, Genk, Belgium (J.P.); and Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, OH (W.H.W.T.).
Wilfried MullensFrom the Department of Cardiology, Ziekenhuis Oost-Limburg, Genk, Belgium (F.H.V., P.N., M.D., W.M.); Doctoral School for Medicine and Life Sciences (F.H.V., P.N.) and Biomedical Research Institute, Faculty of Medicine and Life Sciences (J.P., W.M.), Hasselt University, Diepenbeek, Belgium; Department of Laboratory Medicine, Ziekenhuis Oost-Limburg, Genk, Belgium (J.P.); and Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, OH (W.H.W.T.). wilfried.mullens@zol.be.
Ziekenhuis Oost-Limburg · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe urinary composition, including sodium (Na(+)) and chloride (Cl(-)) concentrations, might provide useful information in addition to urine output during decongestive treatment in heart failure. METHODS AND

resultsConsecutive patients with heart failure (n=61), ejection fraction ≤45%, worsening symptoms, and scheduled treatment with intravenous loop diuretics were included. Patients received protocol-driven therapy until complete decongestion, assessed clinically and by echocardiography. Three consecutive 24-hour urinary collections were performed. With 2 mg (1-4 mg), 1 mg (0-2 mg), and 1 mg (0-1 mg) bumetanide administered in bolus during consecutive 24-hour intervals, in addition to combinational diuretic therapy in ≈70% and both oral spironolactone and vasodilators in ≈90%, euvolemia was reached, often within 24 hours. Urine output was higher during the first when compared with the second or third 24-hour interval (2700 versus 1550 or 1375 mL, respectively; P<0.001), but this was no longer significant after correction for diuretic dose (P=0.263), indicating preserved diuretic efficiency during the study. In contrast, urinary Na(+) and Cl(-) excretion both decreased significantly, even after correction for diuretic dose (P=0.040 and 0.004, respectively), leading to decreasing urinary concentrations with progressive decongestion. After reaching euvolemia, lower urinary Na(+)/Cr and Cl(-)/Cr ratios were both associated with urine output ≤1500 mL (area under the curve, 0.830 and 0.826, respectively; P<0.001 for both), in contrast to plasma N-terminal pro-B-type natriuretic peptide levels that were not (area under the curve, 0.515; P=0.735)

conclusionsThe urinary composition during progressive decongestion in heart failure with reduced ejection fraction is characterized by a drop in urinary Na(+) and Cl(-) concentrations. The urinary Na(+)/Cr or Cl(-)/Cr ratio might provide insightful information to titrate diuretic therapy.

Indexed as

Administration, OralAgedBiomarkersBumetanideChloridesDiureticsDose-Response Relationship, DrugDrug Therapy, CombinationEchocardiographyFemaleHeart FailureHeart VentriclesHumansInjections, IntravenousMaleSodiumBiomarkersBumetanideChloridesDiureticsSodiumSpironolactoneVasodilator Agentssodiumsystolic heart failureureaurine

Identifiers

PMID25037309
OpenAlexW2167809006

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.